Nearly 40,000 bottles of Clear Eyes recalled over sterility concerns

Potential eye infections and temporary adverse health effects possible; 2023 comparable outbreak resulted in one death and 68 injuries including surgical eye removal.
Some patients required surgical removal of the affected eye
The 2023 EzriCare outbreak showed the serious consequences when eye drop contamination reaches consumers.
Mark

Why would a major manufacturer suddenly discover sterility problems in a product that's been on shelves?

Mimi

Manufacturing processes can fail in ways that aren't always obvious until testing catches them. A batch might slip through quality control, or a supplier issue could introduce contamination at some point in production.

Mark

Is this the same kind of problem that happened with EzriCare?

Mimi

Not necessarily the same cause, but the same category of risk. EzriCare had actual bacterial contamination that got into the product. Here, the FDA is saying they can't assure the product is sterile—which could mean contamination was detected, or the sterilization process itself failed for that batch.

Mark

What does "lack of assurance of sterility" actually mean in practical terms?

Mimi

It means the manufacturer or the FDA determined that the normal testing and sterilization procedures either weren't performed correctly or didn't produce reliable results for those bottles. You can't guarantee the product is clean.

Mark

If it's Class II, does that mean it's not that dangerous?

Mimi

Class II means serious harm is unlikely, but temporary problems are possible. It's the middle ground—serious enough to pull from shelves, not serious enough to trigger emergency warnings everywhere.

Mark

What should someone do if they already used some of these drops?

Mimi

Most likely nothing will happen. But if they develop eye redness, discharge, pain, or vision changes in the coming weeks, they should see a doctor and mention they used the recalled product. That helps doctors identify the cause quickly if something is wrong.

  • Nearly 40,000 bottles of a widely trusted over-the-counter eye drop have been pulled from shelves at Walmart, Target, Kroger, and other major chains after sterility could not be confirmed.
  • The specific danger is invisible — contaminated eye drops carry no warning on the label, and infections can escalate quickly in tissue as delicate as the eye.
  • A 2023 outbreak of drug-resistant bacteria in EzriCare Artificial Tears killed one person, injured 68, and left some patients without an eye — giving this recall an urgent historical weight.
  • The FDA has classified the recall as Class II, meaning serious harm is considered unlikely but temporary adverse effects remain a real possibility for anyone who has used the affected lot.
  • Consumers holding bottles marked with lot code 2552A and a September 2027 expiration date are urged to stop use immediately and return them to retailers for a full refund.

When a product designed to soothe the eye becomes a potential source of harm, it reveals how thin the margin is between care and contamination. Prestige Brand Holdings has voluntarily recalled nearly 40,000 bottles of Clear Eyes Maximum Itchy Eye Relief — lot code 2552A, sold at major American retailers — after manufacturing processes failed to guarantee sterility. The FDA's Class II classification suggests the risk is moderate rather than catastrophic, yet the shadow of a 2023 outbreak that blinded and killed reminds us that the eye, open and trusting, is among the most vulnerable places we offer to the world.

Nearly 40,000 bottles of Clear Eyes Maximum Itchy Eye Relief are being pulled from American store shelves after Prestige Brand Holdings discovered the product may not meet sterility standards. The voluntary recall covers 39,060 bottles carrying lot code 2552A with a September 30, 2027 expiration date, distributed through Medtech Products Inc to retailers including Walmart, Target, Kroger, Dollar General, and Family Dollar.

The FDA classified the action as a Class II recall — reserved for moderate-risk situations where contamination could cause temporary or reversible harm, though serious consequences are considered unlikely. The agency's enforcement report cited a "lack of assurance of sterility" as the driving concern. Consumers are instructed to stop using the affected drops immediately and return them for refunds, with pharmacists and healthcare providers available for anyone experiencing symptoms.

The recall carries particular gravity in light of recent history. In 2023, EzriCare Artificial Tears were linked to a Pseudomonas aeruginosa outbreak — a drug-resistant bacterial infection — that sickened 68 people, caused at least one death, and left some patients requiring surgical removal of an eye. That episode established a sobering benchmark for what can happen when sterility fails in products applied directly to the eye.

That Prestige Brand Holdings acted voluntarily suggests the problem was caught before widespread harm occurred. Still, the scale — nearly 40,000 units across multiple retail chains — indicates a significant portion of a production run was affected. Anyone who purchased Clear Eyes Maximum Itchy Eye Relief recently should check their bottle against the specific lot code and expiration date before using it again.

Nearly 40,000 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops are being removed from shelves across the United States after the manufacturer discovered they may not meet sterility standards. Prestige Brand Holdings, headquartered in Tarrytown, New York, initiated the voluntary recall of 39,060 bottles following an FDA alert about potential contamination in the product line.

The affected bottles carry lot code 2552A and are marked with an expiration date of September 30, 2027. The eye drops, distributed through Medtech Products Inc, a subsidiary of Prestige Consumer Healthcare, were sold at major retailers including Walmart, Target, Kroger, Giant Eagle, Meijer, Dollar General, and Family Dollar. The product is formulated as an astringent and lubricant designed to relieve redness, itching, burning, and watery eyes.

The FDA classified this as a Class II recall, a designation reserved for moderate-risk situations where exposure to a contaminated product could cause temporary or reversible health problems, though serious consequences are considered unlikely. The agency's enforcement report specifically cited a "lack of assurance of sterility" as the reason for the action. Consumers who have purchased the recalled bottles are being instructed to stop using them immediately and return them to retailers for refunds. Anyone experiencing symptoms or concerned about potential exposure should consult a pharmacist or healthcare provider.

While eye drop recalls are less frequent than food safety incidents in the United States, they carry particular weight given recent history. In 2023, the FDA recalled EzriCare Artificial Tears after the product became linked to a serious outbreak of Pseudomonas aeruginosa, a drug-resistant bacterium. That contamination event sickened 68 people and resulted in at least one death. Some patients infected through that outbreak required surgical removal of the affected eye, a permanent consequence that underscores the stakes when sterility safeguards fail in products applied directly to the eye.

The Clear Eyes recall serves as a reminder that even widely distributed, over-the-counter products sold under trusted brand names can develop manufacturing issues. The voluntary nature of Prestige Brand Holdings' action suggests the company identified the problem before widespread harm occurred, but the scale of the recall—nearly 40,000 units across multiple retail chains—indicates the contamination risk affected a substantial portion of a production run. Consumers who purchased Clear Eyes Maximum Itchy Eye Relief in recent months should check their bottles against the specific lot code and expiration date to determine whether their product is part of the recall.

Consumers are being advised to stop using the recalled eye drops and return them for a refund.
— FDA guidance
Quieres la nota completa? Lee el original en The Guardian ↗
Contáctanos FAQ